These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10762753)
1. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753 [TBL] [Abstract][Full Text] [Related]
2. Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth. Weber E; Günther D; Laube F; Wiederanders B; Kirschke H J Cancer Res Clin Oncol; 1994; 120(9):564-7. PubMed ID: 8045924 [TBL] [Abstract][Full Text] [Related]
3. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088 [TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Denhardt DT; Greenberg AH; Egan SE; Hamilton RT; Wright JA Oncogene; 1987; 2(1):55-9. PubMed ID: 3438085 [TBL] [Abstract][Full Text] [Related]
5. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Maciewicz RA; Wardale RJ; Etherington DJ; Paraskeva C Int J Cancer; 1989 Mar; 43(3):478-86. PubMed ID: 2647640 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Krueger S; Haeckel C; Buehling F; Roessner A Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250 [TBL] [Abstract][Full Text] [Related]
8. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Krueger S; Kellner U; Buehling F; Roessner A Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774 [TBL] [Abstract][Full Text] [Related]
9. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts. Ravanko K; Järvinen K; Helin J; Kalkkinen N; Hölttä E Cancer Res; 2004 Dec; 64(24):8831-8. PubMed ID: 15604241 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Rousselet N; Mills L; Jean D; Tellez C; Bar-Eli M; Frade R Cancer Res; 2004 Jan; 64(1):146-51. PubMed ID: 14729618 [TBL] [Abstract][Full Text] [Related]
11. Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis. Sol-Church K; Shipley J; Beckman DA; Mason RW Arch Biochem Biophys; 1999 Dec; 372(2):375-81. PubMed ID: 10600178 [TBL] [Abstract][Full Text] [Related]
12. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Frade R; Rodrigues-Lima F; Huang S; Xie K; Guillaume N; Bar-Eli M Cancer Res; 1998 Jul; 58(13):2733-6. PubMed ID: 9661883 [TBL] [Abstract][Full Text] [Related]
14. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts. Achkar C; Gong QM; Frankfater A; Bajkowski AS J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039 [TBL] [Abstract][Full Text] [Related]
15. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Levicar N; Dewey RA; Daley E; Bates TE; Davies D; Kos J; Pilkington GJ; Lah TT Cancer Gene Ther; 2003 Feb; 10(2):141-51. PubMed ID: 12536203 [TBL] [Abstract][Full Text] [Related]
16. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. Baer GS; Ebert DH; Chung CJ; Erickson AH; Dermody TS J Virol; 1999 Nov; 73(11):9532-43. PubMed ID: 10516062 [TBL] [Abstract][Full Text] [Related]
17. Differential expression patterns of cathepsins B, H, K, L and S in the mouse ovary. Oksjoki S; Söderström M; Vuorio E; Anttila L Mol Hum Reprod; 2001 Jan; 7(1):27-34. PubMed ID: 11134357 [TBL] [Abstract][Full Text] [Related]
18. The malignant phenotype and cysteine proteinases. Sloane BF; Rozhin J; Krepela E; Ziegler G; Sameni M Biomed Biochim Acta; 1991; 50(4-6):549-54. PubMed ID: 1801721 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions. Liuzzo JP; Petanceska SS; Moscatelli D; Devi LA Mol Med; 1999 May; 5(5):320-33. PubMed ID: 10390548 [TBL] [Abstract][Full Text] [Related]
20. Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Takahashi H; Ishidoh K; Muno D; Ohwada A; Nukiwa T; Kominami E; Kira S Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1562-8. PubMed ID: 8503570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]